US regulator fast-tracks dementia drug ...News

Russia Today - News
US regulator fast-tracks dementia drug
The FDA approved lecanemab for Alzheimer’s despite alarming side effects The US Food and Drug Administration (FDA) on Friday fast-tracked  the approval of lecanemab, a drug to treat the early stages of Alzheimer’s disease. Made by Japanese drugmaker Eisai and Biogen and marketed as Leqembi, the drug allegedly delays cognitive decline caused by the disease, though trials have shown some alarming side effects. While a clinical trial of lecanemab’s efficacy in early Alzheimer’s disease published in November found it slowed cognitive and functional decline better than a placebo, the researchers noted that it was “asso

Hence then, the article about us regulator fast tracks dementia drug was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US regulator fast-tracks dementia drug )

Apple Storegoogle play

Last updated :

Also on site :